Sign in to view content

Treatment course and outcomes of neovascular age-related macular degeneration in patients receiving intraocular pressure-lowering drops

Bobeck S Modjtahedi, MD

Video
Published 2019

Related

Suprachoroidal Delivery of RGX-314 for Neovascular AMD: Initial Results From the Phase II AAVIATE Study
Mark R. Barakat, MD
Annual Meeting Talks
2021
Safety and Efficacy of CRISPR-Based Genome Editing for Neovascular AMD
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2023
OTX-TKI for the Treatment of Neovascular Age-related Macular Degeneration 12-Month Results From a US Clinical Trial
Robert L. Avery, MD
Annual Meeting Talks
2023

Category: AMD-Neovascular

See more